Genomic landscape of acquired resistance to targeted therapies in patients with solid tumors: A study from the National Center for Precision Medicine (PRISM).
O, that these too too solid tissue samples were free of cross-linked, fragmented, and otherwise degraded RNA. Or that tissue RNA analysis techniques were better at coping with miniscule samples or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback